Parapneumonic effusion and thoracic empyema- Diagnostic principles and nonsurgical treatment;Parapneumonischer erguss und pleuraempyem - Diagnostik und konservative therapie

Deutsche Medizinische Wochenschrift

Volumn 130, Issue 10, 2005, Pages 525-529

  Wagner, Ulrich ^a   Vogelmeier, C ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTODORNASE PLUS STREPTOKINASE; STREPTOKINASE; UROKINASE; ANTIINFECTIVE AGENT; FIBRINOLYTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIOLOGY; DIAGNOSTIC PROCEDURE; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HUMAN; PATHOGENESIS; PLEURA EFFUSION; PLEURA EMPYEMA; PNEUMONIA; REVIEW; BACTERIAL PNEUMONIA; WOUND DRAINAGE;

ANTI-BACTERIAL AGENTS; DRAINAGE; EMPYEMA, PLEURAL; FIBRINOLYTIC AGENTS; HUMANS; PLEURAL EFFUSION; PNEUMONIA, BACTERIAL; STREPTOKINASE; THROMBOLYTIC THERAPY;

EID: 15544369222     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-863086     Document Type: Review

References (17)

1. Brook I, Frazier EH. Aerobic and anaerobic microbiology of empyema: A retrospective review in two military hospitals. Chest 1993; 103: 1502-1507
2. Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev 2004; 2: CD002312
3. Chapman SJ, Davies RJ. Recent advances in parapneumonic effusion and empyema. Curr Opin Pulm Med 2004; 10: 299-304
4. Chen KY, Hsueh PR, Liaw YS et al. A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest 2000; 117: 1685-1689
5. Colice GL, Curtis A, Deslauriers J et al. Medical and surgical treatment of parapneumonic effusions: An evidence-based guideline. Chest 2000; 118: 1158-1171
6. Davies CWH, Gleeson FV, Davies RJO. BTS guidelines for the management of pleural infection. Thorax 2003; 58 (Suppl II); ii18-ii28
7. Davies RJ, Maskell NA, Nunn AJ. Primary results from the UK MRC/BTS randomized trial of streptokinase versus placebo in pleural effusions. Am J Respir Crit Care Med 2004; 169: A861
8. Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997; 52: 416-421
9. Eastham KM, Freeman R, Kearns AM et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 2004; 59: 522-525
10. Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J 1997; 10: 1150-1156
11. Kearney SE, Davies CW, Davies RJ, Gleeson FV. Computed tomography and ultrasound in parapneumonic effusions and empyema. Clin Radiol 2000; 55: 542-547
12. LeMense GP, Strange C, Sahn SA. Empyema thoracis. Therapeutic management and outcome. Chest 1995; 107: 1532-1537
13. Light RW. Diagnostic principles in pleural disease. Eur Respir J 1997; 10:476-481
14. Mavroudis C, Ganzel BL, Cox SK et al. Experimental aerobic anaerobic thoracic empyema in the guinea pig. Ann Thorac Surg 1987; 43: 298-302
15. Strange C, Tomlinson JR, Wilson C et al. The histology of experimental pleural injury with tetracycline, empyema, and carrageenan. Exp Mol Pathol 1989; 51: 205-219
16. Vaudaux P, Waldvogel FA. Gentamicin inactivation in purulent exudates: The role of the cell lysis. J Infect Dis 1980; 142: 586-593
17. Waite RJ, Carbonneau RJ, Balikian JP et al. Parietal pleural changes in empyema: appearances at CT. Radiology 1990; 175: 145-150